SlideShare a Scribd company logo
Woman
Entrepreneur
Kiran Mazumdar-Shaw
Biocon Limited.
INTRODUCTION
Kiran Mazumdar-Shaw (born 23 March 1953) is an Indian entrepreneur. She
is the chairman and managing director of BioconLimited, a biotechnology
company based in Bangalore (Bengaluru), India and the current chairperson of
IIM-Bangalore. In 2014, she was awarded the Othmer Gold Medal, for
outstanding contributions to the progress of science and chemistry. She is on
the Financial Times’ top 50 women in business list. As of 2014, she is listed as
the 92nd most powerful woman in the world byForbes.
Kiran Mazumdar was born to Gujarati parents in Bangalore, India. She went to
school at Bangalore’s Bishop Cotton Girl's High School, graduating in 1968. She
then attended Mount Carmel College, Bangalore, a women's college offering pre-
university courses as an affiliate of Bangalore University. She studied biology and
zoology, graduating from Bangalore University with a B.Sc. in Zoology in
1973. Mazumdar hoped to go to medical school, but did not obtain a scholarship.
Her father, Rasendra Mazumdar, was the head brewmaster at United Breweries.
He suggested that Kiran study fermentation science, and train to be a
brewmaster, a very nontraditional field for a woman. Mazumdar went
to Federation University in Australia to study Malting and Brewing. In 1974 she
was the only woman enrolled in the brewing course, and the top of her
class. She earned the degree of Master Brewer in 1975.
She worked as a trainee brewer in Carlton and United Breweries, Melbourne and
as a trainee maltster at Barrett Brothers and Burston, Australia. She also worked
for some time as a technical consultant at Jupiter Breweries Limited, Calcutta and
as a technical manager at Standard Maltings Corporation, Baroda between 1975
and 1977. However, when she investigated the possibility of further work in
Bangalore or Delhi, she was told that she would not be hired as a master brewer
in India because "It's a man's work." She began to look abroad, and was offered
a position in Scotland.
PROFILE OF THE COMPANY
Biocon Limited (BSE: 532523) is an Indian biopharmaceutical company based
in Bangalore, India. The Company manufactures generic active pharmaceutical
ingredients (APIs) that are sold in the developed markets of the United States and
Europe. It also manufactures biosimilar Insulins, which are sold in India as branded
formulations and in both bulk and formulation forms. In research services, Syngene
International Limited (Syngene) is engaged in the business of custom research in
drug discovery while the other fully owned subsidiary Clinigene International Limited
(Clinigene) is in the clinical development space. In December 2009, Biocon acquired
the Active Pharma Ingredients (API) undertaking from IDL Speciality Chemicals Ltd.,
a subsidiary of Gulf Oil Corporation Limited.
Located with R & D in Bangalore and API unit in Hyderabad, India, Biocon has two
subsidiaries — Syngene, a custom research organisation, and Clinigene, a clinical
research organisation. Biocon’s presence straddles four main therapeutic areas —
Diabetology, Cardiology, Nephrology and Oncology — and plans to introduce two
new divisions, Comprehensive Care, and Immunotherapy, this year.
Biocon’s cardiology, nephrology, diabetology and oncology products including
BESTOR, BASALOGTM, BioMAb EGFR, STATIX, NUFIL safe, INSUGEN, TACROGRAF,
ERYPRO safe, and MYOKINASE are claimed to be considerably less expensive than
other leading brands. Two of its novel programs on the verge of proof-of-concept
stage are IN-105, which is the only oral insulin in the world to be in long duration
clinical trials, and the T1h, a novel humanised monoclonal antibody (MAb), the only
first-in-class novel MAb being tested in India for rheumatoid arthritis and psoriasis.
Between 2005 and 2010, Biocon entered into more than 2,200 high-value R&D
licensing and other deals within the pharmaceuticals and bio-pharmaceutical
space. It has also expanded its global footprint to emerging and developed markets
through acquisitions, partnerships and in-licensing. Biocon’s Corporate Social
Responsibility wing, the Biocon Foundation, is involved in numerous health and
education outreach programs targeting the underprivileged sections of India.
In 2009–10, Biocon’s net income increased 44% to 24,048 million, crossing the
half-billion-dollar mark and profits grew 215% to 2,933 million. The pharmaceutical
business exceeded 200,871 million in revenue and the net R&D expenditure
increased to 917 million, growing 42% over 2008 and up 282% over 2005, while
its research services business crossed 2,807 million.
Biocon, Syngene and Clinigene together employ approximately 4,500 personnel
including biologists, chemists, medical practitioners, pharmacologists, engineers,
finance/legal/marketing analysts, HR generalists and general administrators. Around
6% of its employees have PhD degrees, 45% have a master’s degree, and 33% are
graduates. Biocon also collaborates with educational institutes to make courses more
industry oriented.
CONTRIBUTION TOWARDS THE
UPLIFTING OF THE COMPANY
Biocon Biochemicals of Ireland was acquired from Leslie Auchincloss by Unilever in
1989. The partnership with Unilever helped Biocon to establish global best practises
and quality systems. In 1997, Unilever sold its specialty chemicals division, including
Biocon, to Imperial Chemical Industries (ICI). In 1998, Kiran Mazumdar's fiancée,
Scotsman John Shaw, personally raised $2 million to purchase the outstanding
Biocon shares from ICI. The couple married in 1998, whereupon she became known
as Kiran Mazumdar-Shaw. John Shaw left his position as chairman at Madura Coats
to join Biocon. He became Biocon’s vice chairman in 2001.
In 2004, after seeking the advice of Narayana Murthy, Kiran Mazumdar-Shaw
decided to list Biocon on the stock market. Her intent was to raise capital to further
develop Biocon's research programs. Biocon was the first biotechnology company in
India to issue an IPO. Biocon's IPO was oversubscribed 33 times and its first day at
the bourses closed with a market value of $1.11 billion, making Biocon only the
second Indian company to cross the $1-billion mark on the first day of listing.
CONTRIBUTION TOWARDS
EMPLOYMENT AND THE ECONOMY.
In 2004, Kiran Mazumdar-Shaw started a corporate social responsibility wing at
Biocon, the Biocon Foundation. The Foundation focuses on the areas of health,
education and infrastructure, especially in rural areas of Karnataka which lack
healthcare facilities.
Mazumdar-Shaw dislikes the term "philanthropy", believing that it often provides
temporary fixes rather than changing underlying conditions. She prefers the term
"compassionate capitalist", believing that properly applied business models can
provide an ongoing foundation for sustainable social progress. "Innovation and
commerce are as powerful tools for creating social progress as they are for driving
technological advancement... when they are put to use for social progress, the
implementation is a lot cheaper, a lot more people benefit, and the effect is more
lasting."
Health
India does not have organized health care programs such as socialised medicine or
government-backed health insurance. Rural areas may have only one doctor for
every two thousand people: it is estimated that 70 million people do not have the
money to pay for a doctor's visit or for medicine. The Biocon Foundation is involved
in numerous health and education outreach programs to benefit the economically
weaker sections of Indian society.
Arogya Raksha Yojana
With Dr. Devi Shetty of Narayana Hrudayalaya Hospital, Mazumdar-Shaw has
supported the development of Arogya Raksha Yojana (Disease Protection
Program/Health Help). Through this program Biocon Foundation establishes clinics
to offer clinical care, generic medicines and basic tests for those who cannot afford
them. As of 2010, seven clinics each served a population of 50,000 patients living
within a radius of 10 km, treating in total more than 300,000 people per year. Clinics
organize regular general health checks in remote villages by bringing in physicians
and doctors from network hospitals. To improve early detection of cancer, they have
trained young women as community health workers, using smart phones to send
photographs of suspicious lesions to oncologists at the cancer center. Public health
campaigns such as "Queen of Heart" educate people about specific health issues and
promote early detection of problems such as cardiovascular disease.
The clinics operate on a model of micro-financed health insurance. Biocon provides
low-cost drugs, making a negligible profit on a unit basis, but an overall profit on
volume due to the participation of large numbers of people. Clinics also use a
"subsidised convenience" pricing plan, under which more wealthy patrons pay full
price in return for the convenience of scheduling their visits and procedures at
desirable times, while poorer patients can obtain cheap or even free services by
choosing less desirable times. Doctors and researchers look for opportunities to use
cutting-edge technology in ways that will drive down costs and ensure quality of
service.
Mazumdar-Shaw Cancer Center
The death of her best friend, Nilima Rovshen, and the illnesses of her husband and
her mother from cancer, have motivated Kiran Mazumdar-Shaw to strongly support
cancer research and treatment. In 2009, she established a 1,400-bed cancer care
center, the Mazumdar-Shaw Cancer Center, at the Narayana Health City campus in
Bangalore, collaborating with Dr. Devi Shetty of Narayana Hrudayalaya. In 2011, she
added a center for advanced therapeutics with a bone marrow transplant unit and a
research center. Her goal is to create a world-class cancer center.
Education
In collaboration with collaboration with Mcmillan India Limited and teacher Prathima
Rao, Mazumdar-Shaw has supported development and use of a basic mathematics
textbook, introduced in Kannada schools in 2006.
She funded a multi-year research program by creating the Biocon Cell for Innovation
Management with Dr. Prasad Kaipa at the Indian School of Business in 2009.
Infrastructure
Mazumdar-Shaw speaks openly about the importance of improving India's
infrastructure, emphasizing the need to address issues such as efficient governance,
job creation, and food, water, and health insecurity.
In Bangalore itself, Biocon, Infosys and other companies have had a significant
impact on the city. These companies attract many scientists who would otherwise go
overseas. Once a "pensioner's paradise", Bangalore is now called "the best urban
working environment in India". Biocon Park, built in 2005 not far from Mazumdar-
Shaw's original office, is a ninety-acre campus with five thousand
employees. Outside the developed areas, however, there is still severe poverty.
Mazumdar-Shaw is an energetic proponent of good government and infrastructure.
She supported the Bangalore Agenda Task Force, an initiative of S. M.
Krishna and Nandan Nilekani to improve the city's infrastructure and standard of
living. Mazumdar-Shaw is part of the Bangalore City Connect Foundation, a non-
profit trust for discussion of civic issues, involving both urban stakeholders and the
government. Mazumdar-Shaw is actively engaged in urban reform, partnering with
Jana Urban Space Foundation and local government to improve roads. She is also
involved in the Bangalore Political Action Committee (BPAC), which reviews and
recommends candidates running in elections.
After the 2009 flood, Biocon, Infosys and Wipro all committed to rebuilding homes
for flood victims in north Karnataka. Biocon committed to building 3,000 houses at a
cost of Rs 30 crore.
AWARDS & RECOGNITIONS
Mazumdar-Shaw is the recipient of several prestigious international awards including
the Othmer Gold Medal (2014) for outstanding contributions to the progress of
science and chemistry, the Nikkei Asia Prize (2009) for Regional Growth, the ‘Veuve
Clicquot Initiative For Economic Development For Asia' Award (2007), Ernst & Young
Entrepreneur of the Year Award for Life Sciences & Healthcare (2002), and
'Technology Pioneer' recognition by World Economic Forum (2002). On 05/05/2015
Federation University Australia (Formerly known as University of Ballarat) named a
road in Mt Helen campus as Mazumdar Drive. Kiran and Shaw together attended the
opening function and cut the rippon.
Her pioneering work in the biotechnology sector has earned her numerous national
awards, including the prestigious Padma Shri (1989) and the Padma Bhushan (2005)
from the government of India. She was given the Economic Times Award for
'Businesswoman of the Year' in 2004. At the Pharmaleaders Pharmaceutical
Leadership Summit she was named "Global Indian Woman of the Year" (2012); she
also received the Express Pharmaceutical Leadership Summit Award for "Dynamic
Entrepreneur" in 2009. The Indian Merchants' Chamber Diamond Jubilee
Endowment Trust's Eminent Businessperson of the Year Award was presented to
Kiran Mazumdar-Shaw in 2006 by the Governor of Maharashtra, S. M. Krishna. She
also has received the Indian Chamber of Commerce Lifetime Achievement Award
(2005), the 'Corporate Leadership Award' by the American India Foundation
(2005), and theKarnataka Rajyotsava Award (2002).
CONCLUSION
Kiran Mazumdar-Shaw's pioneering efforts in biotechnology have drawn global
recognition both for Indian Industry and Biocon. Her unique vision has steered
Biocon's transition from an industrial enzymes company to an integrated
biopharmaceutical company with strategic research initiatives. Biocon is today
recognized as India's pioneering biotech enterprise.
She chairs Karnataka's Vision Group on Biotechnology and also served on the Board
of Science Foundation, Ireland. She presently serves on the Advisory Council of the
Government's Department of Biotechnology where she has been instrumental in
bringing government, industry and academia together, to chart a clear and
progressive growth path for Biotechnology in India. Ms. Shaw is also a Board
member of BVGH (Bio-Ventures for Global Health). Most recently, she has been
invited to join the Prime Minister's Council on Trade & Industry in India and the US-
India CEO Forum.
Ms. Shaw is the recipient of several prestigious awards including the ET
Businesswoman of the Year, Best Woman Entrepreneur, Model Employer, Ernst &
Young's Entrepreneur of the Year Award for Life Sciences & Healthcare, Leading
Exporter, Outstanding Citizen, Technology Pioneer, etc. Her most cherished awards
are however, the national awards, PADMASHRI (1989) and PADMA BHUSHAN (2005)
presented to her by the President of India, for her pioneering efforts in Industrial
Biotechnology.
A successful technocrat of global standing, Ms. Shaw is highly respected in the
corporate world. She is a much sought after biotech pioneer who has been referred
to as "India's Biotech Queen" by The Economist and "India's mother of invention" by
New York Times. She was conferred the Wharton- Infosys Business Transformation
Award in 2006 for spearheading the Biotechnology sector in India. Nature
Biotechnology has recently voted her the most influential Bio-business personality
outside Europe and USA.
Ms. Shaw received a graduate honors degree in Zoology from Bangalore University
(1973) and qualified as a Master Brewer from Ballarat University, Australia (1975).
Ms Shaw also received an honorary Doctorate of Science, from her alma mater,
Ballarat University, in recognition of her pre-eminent contributions to the field of
Biotechnology.
She is married to John Shaw, a Scotsman and Indophile, who headed a leading
textiles MNC, Madura Coats from 1991-1998 as Chairman and Managing Director.
John Shaw has since joined Biocon as Director, International Business and is the
Vice Chairman of the Board.

More Related Content

What's hot

Kiran mazumdar shaw
Kiran mazumdar shawKiran mazumdar shaw
Kiran mazumdar shaw
Vikas Gupta
 
45507055 final-project-report-kiran-mazumdar
45507055 final-project-report-kiran-mazumdar45507055 final-project-report-kiran-mazumdar
45507055 final-project-report-kiran-mazumdar
Sunshine LP
 
KIRAN MAZUMDAR SHAW.pptx
KIRAN MAZUMDAR SHAW.pptxKIRAN MAZUMDAR SHAW.pptx
KIRAN MAZUMDAR SHAW.pptx
DhineshM38
 
Azim Premji (Wipro Pvt. ltd)
Azim Premji (Wipro Pvt. ltd)Azim Premji (Wipro Pvt. ltd)
Azim Premji (Wipro Pvt. ltd)
MOHAMMAD Yaseen Dar
 
Dr kiranmazumdarshaw
Dr kiranmazumdarshawDr kiranmazumdarshaw
Dr kiranmazumdarshaw
Abhimanyu Sharma
 
Success story: Kiran Mazumdar
Success story: Kiran MazumdarSuccess story: Kiran Mazumdar
Success story: Kiran Mazumdar
Priya Kadam
 
Kiran mazumdar shaw
Kiran mazumdar shawKiran mazumdar shaw
Kiran mazumdar shaw
Fenella Andrade
 
Karsanbhai khodidas patel
Karsanbhai khodidas patelKarsanbhai khodidas patel
Karsanbhai khodidas patel
Himani Shukla
 
Azim premji ppt (1)
Azim premji ppt (1)Azim premji ppt (1)
Azim premji ppt (1)
Hassan Saeed
 
Azim premji
Azim premjiAzim premji
Azim premji
Gaurav Mukhija
 
Journey of hdfc bank
Journey of hdfc bankJourney of hdfc bank
Journey of hdfc bank
RushikeshHatkar
 
Britannia Industries
Britannia IndustriesBritannia Industries
Britannia Industries
Anup Chakraborty
 
A success story of entrepreneur "Sachin Bansal"
A success story of entrepreneur "Sachin Bansal"A success story of entrepreneur "Sachin Bansal"
A success story of entrepreneur "Sachin Bansal"
NaushamaYasmin
 
presentation on a successful entrepreneur
presentation on a successful entrepreneur presentation on a successful entrepreneur
presentation on a successful entrepreneur
Al Shahriar
 
A successful women entrepreneur
A successful women entrepreneur A successful women entrepreneur
ITC Limited Overview
ITC Limited OverviewITC Limited Overview
ITC Limited Overview
Gaurav Jain
 
Presentation on Azim Premji
Presentation on Azim PremjiPresentation on Azim Premji
Presentation on Azim Premji
Vaibhav Dubey
 
biocon & ms.shaw
biocon & ms.shawbiocon & ms.shaw
biocon & ms.shaw
leo
 
Dove : Evolution of a Brand (HBR Case Study Analysis)
Dove : Evolution of a Brand (HBR Case Study Analysis)Dove : Evolution of a Brand (HBR Case Study Analysis)
Dove : Evolution of a Brand (HBR Case Study Analysis)
Sameer Mathur
 
Kumar mangalam birla
Kumar mangalam birlaKumar mangalam birla

What's hot (20)

Kiran mazumdar shaw
Kiran mazumdar shawKiran mazumdar shaw
Kiran mazumdar shaw
 
45507055 final-project-report-kiran-mazumdar
45507055 final-project-report-kiran-mazumdar45507055 final-project-report-kiran-mazumdar
45507055 final-project-report-kiran-mazumdar
 
KIRAN MAZUMDAR SHAW.pptx
KIRAN MAZUMDAR SHAW.pptxKIRAN MAZUMDAR SHAW.pptx
KIRAN MAZUMDAR SHAW.pptx
 
Azim Premji (Wipro Pvt. ltd)
Azim Premji (Wipro Pvt. ltd)Azim Premji (Wipro Pvt. ltd)
Azim Premji (Wipro Pvt. ltd)
 
Dr kiranmazumdarshaw
Dr kiranmazumdarshawDr kiranmazumdarshaw
Dr kiranmazumdarshaw
 
Success story: Kiran Mazumdar
Success story: Kiran MazumdarSuccess story: Kiran Mazumdar
Success story: Kiran Mazumdar
 
Kiran mazumdar shaw
Kiran mazumdar shawKiran mazumdar shaw
Kiran mazumdar shaw
 
Karsanbhai khodidas patel
Karsanbhai khodidas patelKarsanbhai khodidas patel
Karsanbhai khodidas patel
 
Azim premji ppt (1)
Azim premji ppt (1)Azim premji ppt (1)
Azim premji ppt (1)
 
Azim premji
Azim premjiAzim premji
Azim premji
 
Journey of hdfc bank
Journey of hdfc bankJourney of hdfc bank
Journey of hdfc bank
 
Britannia Industries
Britannia IndustriesBritannia Industries
Britannia Industries
 
A success story of entrepreneur "Sachin Bansal"
A success story of entrepreneur "Sachin Bansal"A success story of entrepreneur "Sachin Bansal"
A success story of entrepreneur "Sachin Bansal"
 
presentation on a successful entrepreneur
presentation on a successful entrepreneur presentation on a successful entrepreneur
presentation on a successful entrepreneur
 
A successful women entrepreneur
A successful women entrepreneur A successful women entrepreneur
A successful women entrepreneur
 
ITC Limited Overview
ITC Limited OverviewITC Limited Overview
ITC Limited Overview
 
Presentation on Azim Premji
Presentation on Azim PremjiPresentation on Azim Premji
Presentation on Azim Premji
 
biocon & ms.shaw
biocon & ms.shawbiocon & ms.shaw
biocon & ms.shaw
 
Dove : Evolution of a Brand (HBR Case Study Analysis)
Dove : Evolution of a Brand (HBR Case Study Analysis)Dove : Evolution of a Brand (HBR Case Study Analysis)
Dove : Evolution of a Brand (HBR Case Study Analysis)
 
Kumar mangalam birla
Kumar mangalam birlaKumar mangalam birla
Kumar mangalam birla
 

Similar to Women entrepenureship project

2012 01 28 life sci succ arya
2012 01 28 life sci succ arya2012 01 28 life sci succ arya
2012 01 28 life sci succ arya
prabhata58
 
What Next After B.Sc., Biotechnology and Microbiology Avenues / Careers
What Next After B.Sc., Biotechnology and Microbiology Avenues / CareersWhat Next After B.Sc., Biotechnology and Microbiology Avenues / Careers
What Next After B.Sc., Biotechnology and Microbiology Avenues / Careers
Dr. Pavan Kundur
 
Biocon Company Profile
Biocon Company ProfileBiocon Company Profile
Biocon Company Profile
Akash Deep Sharma
 
Kiran mazumdar shaw joins U.S. pharmacopeial convention (usp) board of trustees
Kiran mazumdar shaw joins U.S. pharmacopeial convention (usp) board of trusteesKiran mazumdar shaw joins U.S. pharmacopeial convention (usp) board of trustees
Kiran mazumdar shaw joins U.S. pharmacopeial convention (usp) board of trustees
Biocon
 
The famous Indian business women Kiran mazumdar shaw
The famous Indian business women Kiran mazumdar shawThe famous Indian business women Kiran mazumdar shaw
The famous Indian business women Kiran mazumdar shaw
Kunal Sonawane
 
FINAL BROCHURE BIOtech JAPAN 2015
FINAL BROCHURE BIOtech JAPAN 2015FINAL BROCHURE BIOtech JAPAN 2015
FINAL BROCHURE BIOtech JAPAN 2015
Anil Ram Chauhan
 
Biocon
BioconBiocon
Biocon
Navin Kumar
 
Biocon ppt.pptx
Biocon ppt.pptxBiocon ppt.pptx
Biocon ppt.pptx
NIHALMENARIA
 
List of Nutraceutical Manufacturers in India | Pharmaadda
List of Nutraceutical Manufacturers in India | PharmaaddaList of Nutraceutical Manufacturers in India | Pharmaadda
List of Nutraceutical Manufacturers in India | Pharmaadda
AditiMehra14
 
9th Biosimilars Conference Brochure
9th Biosimilars Conference   Brochure9th Biosimilars Conference   Brochure
9th Biosimilars Conference Brochure
sandy_nguyen
 
Kiran Mazumdar Shaw
Kiran Mazumdar ShawKiran Mazumdar Shaw
Kiran Mazumdar Shaw
Bibhushan KC
 
9th Biosimilars (2011) Pp
9th Biosimilars (2011) Pp9th Biosimilars (2011) Pp
9th Biosimilars (2011) Pp
Piyush Patel
 
KIRAN MAZUMDAR SHAW.pptx
KIRAN MAZUMDAR SHAW.pptxKIRAN MAZUMDAR SHAW.pptx
KIRAN MAZUMDAR SHAW.pptx
DhineshM38
 
4 web lsi_aug_sep_2013
4 web lsi_aug_sep_20134 web lsi_aug_sep_2013
4 web lsi_aug_sep_2013
Saji Salam MD,MBA
 
Biotechnology in India
Biotechnology in IndiaBiotechnology in India
Biotechnology in India
Bhagyashree Srivastava
 
Biocon announces that it has entered into an option agreement with Bristol-My...
Biocon announces that it has entered into an option agreement with Bristol-My...Biocon announces that it has entered into an option agreement with Bristol-My...
Biocon announces that it has entered into an option agreement with Bristol-My...
Biocon
 
Biotech in Bangalore: Seminar programme
Biotech in Bangalore: Seminar programmeBiotech in Bangalore: Seminar programme
Biotech in Bangalore: Seminar programme
STEPS Centre
 
PROBIOTIC FUNCTIONAL FOOD VS DRUGS: IMPACT OF INDIAN REGULATORY STATUS ON DES...
PROBIOTIC FUNCTIONAL FOOD VS DRUGS: IMPACT OF INDIAN REGULATORY STATUS ON DES...PROBIOTIC FUNCTIONAL FOOD VS DRUGS: IMPACT OF INDIAN REGULATORY STATUS ON DES...
PROBIOTIC FUNCTIONAL FOOD VS DRUGS: IMPACT OF INDIAN REGULATORY STATUS ON DES...
Neetu singh
 
Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...
National Institute of Biologics
 
Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...
National Institute of Biologics
 

Similar to Women entrepenureship project (20)

2012 01 28 life sci succ arya
2012 01 28 life sci succ arya2012 01 28 life sci succ arya
2012 01 28 life sci succ arya
 
What Next After B.Sc., Biotechnology and Microbiology Avenues / Careers
What Next After B.Sc., Biotechnology and Microbiology Avenues / CareersWhat Next After B.Sc., Biotechnology and Microbiology Avenues / Careers
What Next After B.Sc., Biotechnology and Microbiology Avenues / Careers
 
Biocon Company Profile
Biocon Company ProfileBiocon Company Profile
Biocon Company Profile
 
Kiran mazumdar shaw joins U.S. pharmacopeial convention (usp) board of trustees
Kiran mazumdar shaw joins U.S. pharmacopeial convention (usp) board of trusteesKiran mazumdar shaw joins U.S. pharmacopeial convention (usp) board of trustees
Kiran mazumdar shaw joins U.S. pharmacopeial convention (usp) board of trustees
 
The famous Indian business women Kiran mazumdar shaw
The famous Indian business women Kiran mazumdar shawThe famous Indian business women Kiran mazumdar shaw
The famous Indian business women Kiran mazumdar shaw
 
FINAL BROCHURE BIOtech JAPAN 2015
FINAL BROCHURE BIOtech JAPAN 2015FINAL BROCHURE BIOtech JAPAN 2015
FINAL BROCHURE BIOtech JAPAN 2015
 
Biocon
BioconBiocon
Biocon
 
Biocon ppt.pptx
Biocon ppt.pptxBiocon ppt.pptx
Biocon ppt.pptx
 
List of Nutraceutical Manufacturers in India | Pharmaadda
List of Nutraceutical Manufacturers in India | PharmaaddaList of Nutraceutical Manufacturers in India | Pharmaadda
List of Nutraceutical Manufacturers in India | Pharmaadda
 
9th Biosimilars Conference Brochure
9th Biosimilars Conference   Brochure9th Biosimilars Conference   Brochure
9th Biosimilars Conference Brochure
 
Kiran Mazumdar Shaw
Kiran Mazumdar ShawKiran Mazumdar Shaw
Kiran Mazumdar Shaw
 
9th Biosimilars (2011) Pp
9th Biosimilars (2011) Pp9th Biosimilars (2011) Pp
9th Biosimilars (2011) Pp
 
KIRAN MAZUMDAR SHAW.pptx
KIRAN MAZUMDAR SHAW.pptxKIRAN MAZUMDAR SHAW.pptx
KIRAN MAZUMDAR SHAW.pptx
 
4 web lsi_aug_sep_2013
4 web lsi_aug_sep_20134 web lsi_aug_sep_2013
4 web lsi_aug_sep_2013
 
Biotechnology in India
Biotechnology in IndiaBiotechnology in India
Biotechnology in India
 
Biocon announces that it has entered into an option agreement with Bristol-My...
Biocon announces that it has entered into an option agreement with Bristol-My...Biocon announces that it has entered into an option agreement with Bristol-My...
Biocon announces that it has entered into an option agreement with Bristol-My...
 
Biotech in Bangalore: Seminar programme
Biotech in Bangalore: Seminar programmeBiotech in Bangalore: Seminar programme
Biotech in Bangalore: Seminar programme
 
PROBIOTIC FUNCTIONAL FOOD VS DRUGS: IMPACT OF INDIAN REGULATORY STATUS ON DES...
PROBIOTIC FUNCTIONAL FOOD VS DRUGS: IMPACT OF INDIAN REGULATORY STATUS ON DES...PROBIOTIC FUNCTIONAL FOOD VS DRUGS: IMPACT OF INDIAN REGULATORY STATUS ON DES...
PROBIOTIC FUNCTIONAL FOOD VS DRUGS: IMPACT OF INDIAN REGULATORY STATUS ON DES...
 
Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...
 
Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...
 

Recently uploaded

Understanding User Needs and Satisfying Them
Understanding User Needs and Satisfying ThemUnderstanding User Needs and Satisfying Them
Understanding User Needs and Satisfying Them
Aggregage
 
Creative Web Design Company in Singapore
Creative Web Design Company in SingaporeCreative Web Design Company in Singapore
Creative Web Design Company in Singapore
techboxsqauremedia
 
Top mailing list providers in the USA.pptx
Top mailing list providers in the USA.pptxTop mailing list providers in the USA.pptx
Top mailing list providers in the USA.pptx
JeremyPeirce1
 
The latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from NewentideThe latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from Newentide
JoeYangGreatMachiner
 
Call8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessingCall8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessing
➑➌➋➑➒➎➑➑➊➍
 
Observation Lab PowerPoint Assignment for TEM 431
Observation Lab PowerPoint Assignment for TEM 431Observation Lab PowerPoint Assignment for TEM 431
Observation Lab PowerPoint Assignment for TEM 431
ecamare2
 
Business storytelling: key ingredients to a story
Business storytelling: key ingredients to a storyBusiness storytelling: key ingredients to a story
Business storytelling: key ingredients to a story
Alexandra Fulford
 
How to Implement a Real Estate CRM Software
How to Implement a Real Estate CRM SoftwareHow to Implement a Real Estate CRM Software
How to Implement a Real Estate CRM Software
SalesTown
 
Easily Verify Compliance and Security with Binance KYC
Easily Verify Compliance and Security with Binance KYCEasily Verify Compliance and Security with Binance KYC
Easily Verify Compliance and Security with Binance KYC
Any kyc Account
 
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel ChartSatta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
➒➌➎➏➑➐➋➑➐➐Dpboss Matka Guessing Satta Matka Kalyan Chart Indian Matka
 
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
my Pandit
 
Call 8867766396 Satta Matka Dpboss Matka Guessing Satta batta Matka 420 Satta...
Call 8867766396 Satta Matka Dpboss Matka Guessing Satta batta Matka 420 Satta...Call 8867766396 Satta Matka Dpboss Matka Guessing Satta batta Matka 420 Satta...
Call 8867766396 Satta Matka Dpboss Matka Guessing Satta batta Matka 420 Satta...
bosssp10
 
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
APCO
 
GKohler - Retail Scavenger Hunt Presentation
GKohler - Retail Scavenger Hunt PresentationGKohler - Retail Scavenger Hunt Presentation
GKohler - Retail Scavenger Hunt Presentation
GraceKohler1
 
3 Simple Steps To Buy Verified Payoneer Account In 2024
3 Simple Steps To Buy Verified Payoneer Account In 20243 Simple Steps To Buy Verified Payoneer Account In 2024
3 Simple Steps To Buy Verified Payoneer Account In 2024
SEOSMMEARTH
 
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
Lacey Max
 
Part 2 Deep Dive: Navigating the 2024 Slowdown
Part 2 Deep Dive: Navigating the 2024 SlowdownPart 2 Deep Dive: Navigating the 2024 Slowdown
Part 2 Deep Dive: Navigating the 2024 Slowdown
jeffkluth1
 
Lundin Gold Corporate Presentation - June 2024
Lundin Gold Corporate Presentation - June 2024Lundin Gold Corporate Presentation - June 2024
Lundin Gold Corporate Presentation - June 2024
Adnet Communications
 
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Neil Horowitz
 
Building Your Employer Brand with Social Media
Building Your Employer Brand with Social MediaBuilding Your Employer Brand with Social Media
Building Your Employer Brand with Social Media
LuanWise
 

Recently uploaded (20)

Understanding User Needs and Satisfying Them
Understanding User Needs and Satisfying ThemUnderstanding User Needs and Satisfying Them
Understanding User Needs and Satisfying Them
 
Creative Web Design Company in Singapore
Creative Web Design Company in SingaporeCreative Web Design Company in Singapore
Creative Web Design Company in Singapore
 
Top mailing list providers in the USA.pptx
Top mailing list providers in the USA.pptxTop mailing list providers in the USA.pptx
Top mailing list providers in the USA.pptx
 
The latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from NewentideThe latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from Newentide
 
Call8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessingCall8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessing
 
Observation Lab PowerPoint Assignment for TEM 431
Observation Lab PowerPoint Assignment for TEM 431Observation Lab PowerPoint Assignment for TEM 431
Observation Lab PowerPoint Assignment for TEM 431
 
Business storytelling: key ingredients to a story
Business storytelling: key ingredients to a storyBusiness storytelling: key ingredients to a story
Business storytelling: key ingredients to a story
 
How to Implement a Real Estate CRM Software
How to Implement a Real Estate CRM SoftwareHow to Implement a Real Estate CRM Software
How to Implement a Real Estate CRM Software
 
Easily Verify Compliance and Security with Binance KYC
Easily Verify Compliance and Security with Binance KYCEasily Verify Compliance and Security with Binance KYC
Easily Verify Compliance and Security with Binance KYC
 
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel ChartSatta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
 
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
 
Call 8867766396 Satta Matka Dpboss Matka Guessing Satta batta Matka 420 Satta...
Call 8867766396 Satta Matka Dpboss Matka Guessing Satta batta Matka 420 Satta...Call 8867766396 Satta Matka Dpboss Matka Guessing Satta batta Matka 420 Satta...
Call 8867766396 Satta Matka Dpboss Matka Guessing Satta batta Matka 420 Satta...
 
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
 
GKohler - Retail Scavenger Hunt Presentation
GKohler - Retail Scavenger Hunt PresentationGKohler - Retail Scavenger Hunt Presentation
GKohler - Retail Scavenger Hunt Presentation
 
3 Simple Steps To Buy Verified Payoneer Account In 2024
3 Simple Steps To Buy Verified Payoneer Account In 20243 Simple Steps To Buy Verified Payoneer Account In 2024
3 Simple Steps To Buy Verified Payoneer Account In 2024
 
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
 
Part 2 Deep Dive: Navigating the 2024 Slowdown
Part 2 Deep Dive: Navigating the 2024 SlowdownPart 2 Deep Dive: Navigating the 2024 Slowdown
Part 2 Deep Dive: Navigating the 2024 Slowdown
 
Lundin Gold Corporate Presentation - June 2024
Lundin Gold Corporate Presentation - June 2024Lundin Gold Corporate Presentation - June 2024
Lundin Gold Corporate Presentation - June 2024
 
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
 
Building Your Employer Brand with Social Media
Building Your Employer Brand with Social MediaBuilding Your Employer Brand with Social Media
Building Your Employer Brand with Social Media
 

Women entrepenureship project

  • 2. INTRODUCTION Kiran Mazumdar-Shaw (born 23 March 1953) is an Indian entrepreneur. She is the chairman and managing director of BioconLimited, a biotechnology company based in Bangalore (Bengaluru), India and the current chairperson of IIM-Bangalore. In 2014, she was awarded the Othmer Gold Medal, for outstanding contributions to the progress of science and chemistry. She is on the Financial Times’ top 50 women in business list. As of 2014, she is listed as the 92nd most powerful woman in the world byForbes. Kiran Mazumdar was born to Gujarati parents in Bangalore, India. She went to school at Bangalore’s Bishop Cotton Girl's High School, graduating in 1968. She then attended Mount Carmel College, Bangalore, a women's college offering pre- university courses as an affiliate of Bangalore University. She studied biology and zoology, graduating from Bangalore University with a B.Sc. in Zoology in 1973. Mazumdar hoped to go to medical school, but did not obtain a scholarship. Her father, Rasendra Mazumdar, was the head brewmaster at United Breweries. He suggested that Kiran study fermentation science, and train to be a brewmaster, a very nontraditional field for a woman. Mazumdar went to Federation University in Australia to study Malting and Brewing. In 1974 she was the only woman enrolled in the brewing course, and the top of her class. She earned the degree of Master Brewer in 1975. She worked as a trainee brewer in Carlton and United Breweries, Melbourne and as a trainee maltster at Barrett Brothers and Burston, Australia. She also worked for some time as a technical consultant at Jupiter Breweries Limited, Calcutta and as a technical manager at Standard Maltings Corporation, Baroda between 1975 and 1977. However, when she investigated the possibility of further work in Bangalore or Delhi, she was told that she would not be hired as a master brewer in India because "It's a man's work." She began to look abroad, and was offered a position in Scotland.
  • 3. PROFILE OF THE COMPANY Biocon Limited (BSE: 532523) is an Indian biopharmaceutical company based in Bangalore, India. The Company manufactures generic active pharmaceutical ingredients (APIs) that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar Insulins, which are sold in India as branded formulations and in both bulk and formulation forms. In research services, Syngene International Limited (Syngene) is engaged in the business of custom research in drug discovery while the other fully owned subsidiary Clinigene International Limited (Clinigene) is in the clinical development space. In December 2009, Biocon acquired the Active Pharma Ingredients (API) undertaking from IDL Speciality Chemicals Ltd., a subsidiary of Gulf Oil Corporation Limited. Located with R & D in Bangalore and API unit in Hyderabad, India, Biocon has two subsidiaries — Syngene, a custom research organisation, and Clinigene, a clinical research organisation. Biocon’s presence straddles four main therapeutic areas — Diabetology, Cardiology, Nephrology and Oncology — and plans to introduce two new divisions, Comprehensive Care, and Immunotherapy, this year. Biocon’s cardiology, nephrology, diabetology and oncology products including BESTOR, BASALOGTM, BioMAb EGFR, STATIX, NUFIL safe, INSUGEN, TACROGRAF, ERYPRO safe, and MYOKINASE are claimed to be considerably less expensive than other leading brands. Two of its novel programs on the verge of proof-of-concept stage are IN-105, which is the only oral insulin in the world to be in long duration clinical trials, and the T1h, a novel humanised monoclonal antibody (MAb), the only first-in-class novel MAb being tested in India for rheumatoid arthritis and psoriasis. Between 2005 and 2010, Biocon entered into more than 2,200 high-value R&D licensing and other deals within the pharmaceuticals and bio-pharmaceutical space. It has also expanded its global footprint to emerging and developed markets through acquisitions, partnerships and in-licensing. Biocon’s Corporate Social Responsibility wing, the Biocon Foundation, is involved in numerous health and education outreach programs targeting the underprivileged sections of India. In 2009–10, Biocon’s net income increased 44% to 24,048 million, crossing the half-billion-dollar mark and profits grew 215% to 2,933 million. The pharmaceutical business exceeded 200,871 million in revenue and the net R&D expenditure increased to 917 million, growing 42% over 2008 and up 282% over 2005, while its research services business crossed 2,807 million.
  • 4. Biocon, Syngene and Clinigene together employ approximately 4,500 personnel including biologists, chemists, medical practitioners, pharmacologists, engineers, finance/legal/marketing analysts, HR generalists and general administrators. Around 6% of its employees have PhD degrees, 45% have a master’s degree, and 33% are graduates. Biocon also collaborates with educational institutes to make courses more industry oriented.
  • 5. CONTRIBUTION TOWARDS THE UPLIFTING OF THE COMPANY Biocon Biochemicals of Ireland was acquired from Leslie Auchincloss by Unilever in 1989. The partnership with Unilever helped Biocon to establish global best practises and quality systems. In 1997, Unilever sold its specialty chemicals division, including Biocon, to Imperial Chemical Industries (ICI). In 1998, Kiran Mazumdar's fiancée, Scotsman John Shaw, personally raised $2 million to purchase the outstanding Biocon shares from ICI. The couple married in 1998, whereupon she became known as Kiran Mazumdar-Shaw. John Shaw left his position as chairman at Madura Coats to join Biocon. He became Biocon’s vice chairman in 2001. In 2004, after seeking the advice of Narayana Murthy, Kiran Mazumdar-Shaw decided to list Biocon on the stock market. Her intent was to raise capital to further develop Biocon's research programs. Biocon was the first biotechnology company in India to issue an IPO. Biocon's IPO was oversubscribed 33 times and its first day at the bourses closed with a market value of $1.11 billion, making Biocon only the second Indian company to cross the $1-billion mark on the first day of listing.
  • 6. CONTRIBUTION TOWARDS EMPLOYMENT AND THE ECONOMY. In 2004, Kiran Mazumdar-Shaw started a corporate social responsibility wing at Biocon, the Biocon Foundation. The Foundation focuses on the areas of health, education and infrastructure, especially in rural areas of Karnataka which lack healthcare facilities. Mazumdar-Shaw dislikes the term "philanthropy", believing that it often provides temporary fixes rather than changing underlying conditions. She prefers the term "compassionate capitalist", believing that properly applied business models can provide an ongoing foundation for sustainable social progress. "Innovation and commerce are as powerful tools for creating social progress as they are for driving technological advancement... when they are put to use for social progress, the implementation is a lot cheaper, a lot more people benefit, and the effect is more lasting." Health India does not have organized health care programs such as socialised medicine or government-backed health insurance. Rural areas may have only one doctor for every two thousand people: it is estimated that 70 million people do not have the money to pay for a doctor's visit or for medicine. The Biocon Foundation is involved in numerous health and education outreach programs to benefit the economically weaker sections of Indian society. Arogya Raksha Yojana With Dr. Devi Shetty of Narayana Hrudayalaya Hospital, Mazumdar-Shaw has supported the development of Arogya Raksha Yojana (Disease Protection Program/Health Help). Through this program Biocon Foundation establishes clinics to offer clinical care, generic medicines and basic tests for those who cannot afford them. As of 2010, seven clinics each served a population of 50,000 patients living within a radius of 10 km, treating in total more than 300,000 people per year. Clinics organize regular general health checks in remote villages by bringing in physicians and doctors from network hospitals. To improve early detection of cancer, they have trained young women as community health workers, using smart phones to send photographs of suspicious lesions to oncologists at the cancer center. Public health
  • 7. campaigns such as "Queen of Heart" educate people about specific health issues and promote early detection of problems such as cardiovascular disease. The clinics operate on a model of micro-financed health insurance. Biocon provides low-cost drugs, making a negligible profit on a unit basis, but an overall profit on volume due to the participation of large numbers of people. Clinics also use a "subsidised convenience" pricing plan, under which more wealthy patrons pay full price in return for the convenience of scheduling their visits and procedures at desirable times, while poorer patients can obtain cheap or even free services by choosing less desirable times. Doctors and researchers look for opportunities to use cutting-edge technology in ways that will drive down costs and ensure quality of service. Mazumdar-Shaw Cancer Center The death of her best friend, Nilima Rovshen, and the illnesses of her husband and her mother from cancer, have motivated Kiran Mazumdar-Shaw to strongly support cancer research and treatment. In 2009, she established a 1,400-bed cancer care center, the Mazumdar-Shaw Cancer Center, at the Narayana Health City campus in Bangalore, collaborating with Dr. Devi Shetty of Narayana Hrudayalaya. In 2011, she added a center for advanced therapeutics with a bone marrow transplant unit and a research center. Her goal is to create a world-class cancer center. Education In collaboration with collaboration with Mcmillan India Limited and teacher Prathima Rao, Mazumdar-Shaw has supported development and use of a basic mathematics textbook, introduced in Kannada schools in 2006. She funded a multi-year research program by creating the Biocon Cell for Innovation Management with Dr. Prasad Kaipa at the Indian School of Business in 2009. Infrastructure Mazumdar-Shaw speaks openly about the importance of improving India's infrastructure, emphasizing the need to address issues such as efficient governance, job creation, and food, water, and health insecurity. In Bangalore itself, Biocon, Infosys and other companies have had a significant impact on the city. These companies attract many scientists who would otherwise go overseas. Once a "pensioner's paradise", Bangalore is now called "the best urban working environment in India". Biocon Park, built in 2005 not far from Mazumdar-
  • 8. Shaw's original office, is a ninety-acre campus with five thousand employees. Outside the developed areas, however, there is still severe poverty. Mazumdar-Shaw is an energetic proponent of good government and infrastructure. She supported the Bangalore Agenda Task Force, an initiative of S. M. Krishna and Nandan Nilekani to improve the city's infrastructure and standard of living. Mazumdar-Shaw is part of the Bangalore City Connect Foundation, a non- profit trust for discussion of civic issues, involving both urban stakeholders and the government. Mazumdar-Shaw is actively engaged in urban reform, partnering with Jana Urban Space Foundation and local government to improve roads. She is also involved in the Bangalore Political Action Committee (BPAC), which reviews and recommends candidates running in elections. After the 2009 flood, Biocon, Infosys and Wipro all committed to rebuilding homes for flood victims in north Karnataka. Biocon committed to building 3,000 houses at a cost of Rs 30 crore. AWARDS & RECOGNITIONS Mazumdar-Shaw is the recipient of several prestigious international awards including the Othmer Gold Medal (2014) for outstanding contributions to the progress of science and chemistry, the Nikkei Asia Prize (2009) for Regional Growth, the ‘Veuve Clicquot Initiative For Economic Development For Asia' Award (2007), Ernst & Young Entrepreneur of the Year Award for Life Sciences & Healthcare (2002), and 'Technology Pioneer' recognition by World Economic Forum (2002). On 05/05/2015 Federation University Australia (Formerly known as University of Ballarat) named a road in Mt Helen campus as Mazumdar Drive. Kiran and Shaw together attended the opening function and cut the rippon. Her pioneering work in the biotechnology sector has earned her numerous national awards, including the prestigious Padma Shri (1989) and the Padma Bhushan (2005) from the government of India. She was given the Economic Times Award for 'Businesswoman of the Year' in 2004. At the Pharmaleaders Pharmaceutical Leadership Summit she was named "Global Indian Woman of the Year" (2012); she also received the Express Pharmaceutical Leadership Summit Award for "Dynamic Entrepreneur" in 2009. The Indian Merchants' Chamber Diamond Jubilee Endowment Trust's Eminent Businessperson of the Year Award was presented to Kiran Mazumdar-Shaw in 2006 by the Governor of Maharashtra, S. M. Krishna. She also has received the Indian Chamber of Commerce Lifetime Achievement Award (2005), the 'Corporate Leadership Award' by the American India Foundation (2005), and theKarnataka Rajyotsava Award (2002).
  • 9. CONCLUSION Kiran Mazumdar-Shaw's pioneering efforts in biotechnology have drawn global recognition both for Indian Industry and Biocon. Her unique vision has steered Biocon's transition from an industrial enzymes company to an integrated biopharmaceutical company with strategic research initiatives. Biocon is today recognized as India's pioneering biotech enterprise. She chairs Karnataka's Vision Group on Biotechnology and also served on the Board of Science Foundation, Ireland. She presently serves on the Advisory Council of the Government's Department of Biotechnology where she has been instrumental in bringing government, industry and academia together, to chart a clear and progressive growth path for Biotechnology in India. Ms. Shaw is also a Board member of BVGH (Bio-Ventures for Global Health). Most recently, she has been invited to join the Prime Minister's Council on Trade & Industry in India and the US- India CEO Forum. Ms. Shaw is the recipient of several prestigious awards including the ET Businesswoman of the Year, Best Woman Entrepreneur, Model Employer, Ernst & Young's Entrepreneur of the Year Award for Life Sciences & Healthcare, Leading Exporter, Outstanding Citizen, Technology Pioneer, etc. Her most cherished awards are however, the national awards, PADMASHRI (1989) and PADMA BHUSHAN (2005) presented to her by the President of India, for her pioneering efforts in Industrial Biotechnology. A successful technocrat of global standing, Ms. Shaw is highly respected in the corporate world. She is a much sought after biotech pioneer who has been referred to as "India's Biotech Queen" by The Economist and "India's mother of invention" by New York Times. She was conferred the Wharton- Infosys Business Transformation Award in 2006 for spearheading the Biotechnology sector in India. Nature Biotechnology has recently voted her the most influential Bio-business personality outside Europe and USA. Ms. Shaw received a graduate honors degree in Zoology from Bangalore University (1973) and qualified as a Master Brewer from Ballarat University, Australia (1975). Ms Shaw also received an honorary Doctorate of Science, from her alma mater, Ballarat University, in recognition of her pre-eminent contributions to the field of Biotechnology. She is married to John Shaw, a Scotsman and Indophile, who headed a leading textiles MNC, Madura Coats from 1991-1998 as Chairman and Managing Director. John Shaw has since joined Biocon as Director, International Business and is the Vice Chairman of the Board.